UBS Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.9M | Sell |
736,223
-320,627
| -30% | -$6.92M | ﹤0.01% | 2059 |
|
2025
Q1 | $17.6M | Sell |
1,056,850
-184,425
| -15% | -$3.06M | ﹤0.01% | 1900 |
|
2024
Q4 | $22.8M | Buy |
1,241,275
+637,123
| +105% | +$11.7M | ﹤0.01% | 1663 |
|
2024
Q3 | $9.29M | Buy |
604,152
+148,601
| +33% | +$2.29M | ﹤0.01% | 1737 |
|
2024
Q2 | $7.4M | Buy |
455,551
+111,670
| +32% | +$1.81M | ﹤0.01% | 1820 |
|
2024
Q1 | $6.36M | Buy |
343,881
+36,522
| +12% | +$675K | ﹤0.01% | 1976 |
|
2023
Q4 | $9.62M | Buy |
307,359
+162,663
| +112% | +$5.09M | ﹤0.01% | 1491 |
|
2023
Q3 | $3.02M | Buy |
144,696
+4,995
| +4% | +$104K | ﹤0.01% | 2229 |
|
2023
Q2 | $3.35M | Sell |
139,701
-13,490
| -9% | -$323K | ﹤0.01% | 2240 |
|
2023
Q1 | $2.88M | Sell |
153,191
-214,128
| -58% | -$4.03M | ﹤0.01% | 2269 |
|
2022
Q4 | $5.85M | Buy |
367,319
+316,246
| +619% | +$5.03M | ﹤0.01% | 1711 |
|
2022
Q3 | $835K | Buy |
51,073
+17,271
| +51% | +$282K | ﹤0.01% | 2992 |
|
2022
Q2 | $477K | Sell |
33,802
-29,631
| -47% | -$418K | ﹤0.01% | 3372 |
|
2022
Q1 | $1.54M | Sell |
63,433
-155,475
| -71% | -$3.77M | ﹤0.01% | 2875 |
|
2021
Q4 | $5.11M | Buy |
218,908
+1,405
| +0.6% | +$32.8K | ﹤0.01% | 2068 |
|
2021
Q3 | $3.61M | Buy |
217,503
+205,648
| +1,735% | +$3.42M | ﹤0.01% | 2290 |
|
2021
Q2 | $289K | Sell |
11,855
-15,080
| -56% | -$368K | ﹤0.01% | 4097 |
|
2021
Q1 | $695K | Sell |
26,935
-11,726
| -30% | -$303K | ﹤0.01% | 3669 |
|
2020
Q4 | $2.07M | Buy |
38,661
+8,283
| +27% | +$443K | ﹤0.01% | 2610 |
|
2020
Q3 | $1.25M | Buy |
30,378
+5,951
| +24% | +$245K | ﹤0.01% | 2777 |
|
2020
Q2 | $1.18M | Buy |
24,427
+422
| +2% | +$20.5K | ﹤0.01% | 2687 |
|
2020
Q1 | $1.01M | Sell |
24,005
-115,667
| -83% | -$4.89M | ﹤0.01% | 2643 |
|
2019
Q4 | $5.98M | Buy |
139,672
+20,250
| +17% | +$866K | ﹤0.01% | 1881 |
|
2019
Q3 | $4.3M | Buy |
119,422
+60,565
| +103% | +$2.18M | ﹤0.01% | 1976 |
|
2019
Q2 | $1.57M | Sell |
58,857
-20,150
| -26% | -$539K | ﹤0.01% | 2701 |
|
2019
Q1 | $2.12M | Sell |
79,007
-226,807
| -74% | -$6.09M | ﹤0.01% | 2381 |
|
2018
Q4 | $4.95M | Sell |
305,814
-3,860
| -1% | -$62.4K | ﹤0.01% | 1703 |
|
2018
Q3 | $6.43M | Buy |
309,674
+131,931
| +74% | +$2.74M | ﹤0.01% | 1697 |
|
2018
Q2 | $2.71M | Sell |
177,743
-261,344
| -60% | -$3.99M | ﹤0.01% | 2310 |
|
2018
Q1 | $9.87M | Buy |
439,087
+221,465
| +102% | +$4.98M | ﹤0.01% | 1344 |
|
2017
Q4 | $6.55M | Sell |
217,622
-35,213
| -14% | -$1.06M | ﹤0.01% | 1630 |
|
2017
Q3 | $9.52M | Buy |
252,835
+7,955
| +3% | +$300K | ﹤0.01% | 1297 |
|
2017
Q2 | $6.83M | Buy |
244,880
+165,503
| +209% | +$4.62M | ﹤0.01% | 1459 |
|
2017
Q1 | $2.73M | Sell |
79,377
-104,105
| -57% | -$3.58M | ﹤0.01% | 2094 |
|
2016
Q4 | $5.29M | Buy |
183,482
+25,472
| +16% | +$735K | ﹤0.01% | 1552 |
|
2016
Q3 | $5.03M | Sell |
158,010
-29,577
| -16% | -$941K | ﹤0.01% | 1543 |
|
2016
Q2 | $6.09M | Buy |
187,587
+170,485
| +997% | +$5.53M | ﹤0.01% | 1360 |
|
2016
Q1 | $479K | Buy |
17,102
+4,158
| +32% | +$116K | ﹤0.01% | 3151 |
|
2015
Q4 | $461K | Sell |
12,944
-40,084
| -76% | -$1.43M | ﹤0.01% | 3210 |
|
2015
Q3 | $1.75M | Buy |
53,028
+35,413
| +201% | +$1.17M | ﹤0.01% | 2240 |
|
2015
Q2 | $738K | Buy |
17,615
+2,511
| +17% | +$105K | ﹤0.01% | 2998 |
|
2015
Q1 | $492K | Sell |
15,104
-23,617
| -61% | -$769K | ﹤0.01% | 3239 |
|
2014
Q4 | $1.23M | Buy |
+38,721
| New | +$1.23M | ﹤0.01% | 2605 |
|